Application of Cut-Points for Low Muscle Strength and Lean Mass in Mobility-Limited Older Adults
- PMID: 32633836
- PMCID: PMC7440655
- DOI: 10.1111/jgs.16525
Application of Cut-Points for Low Muscle Strength and Lean Mass in Mobility-Limited Older Adults
Abstract
Background: The Sarcopenia Definitions and Outcomes Consortium (SDOC) is a collaborative initiative seeking to develop and evaluate cut-points for low muscle strength and lean mass that predict an increased risk for slowness (usual walking speed <.8 m/s) among older adults.
Objectives: The goal of the present study was to provide clinicians and researchers with an understanding of the diagnostic implications of using SDOC variables and cut-points in mobility-limited older adults. Using data from older individuals with specific conditions that render them at increased risk for mobility limitation, we evaluated the performance characteristics (ie, sensitivity and specificity) of five putative sarcopenia parameters and then compared these values with previously recommended diagnostic criteria for sarcopenia.
Design: Retrospective analysis of six randomized controlled trials enriched in persons at risk for mobility limitation.
Setting: National and international geriatric clinical research centers.
Participants: A total of 925 mobility-limited older adults (≥55 years of age; 58% women) were included in the analysis.
Measurements: The prevalence of low muscle strength and lean mass were assessed using five candidate metrics discriminative of slowness. Analyses of sensitivity and specificity were used to compare muscle weakness criteria with published diagnostics for sarcopenia.
Results: Odds ratios (ORs) supported maximal grip strength (Grip max <35.5 and 20.0 in men and women, respectively) as the most discriminative of slowness in both men and women (OR = 3.66 and 3.53, respectively). More men (58%) than women (30%) fell below sex-specific maximal grip cut-points. When applying previously recommended sarcopenia component definitions in our population, we found that fewer individuals met those criteria (range = 6%-32%).
Conclusion: A greater number of individuals fall below SDOC Grip max cut-points compared with previous recommendations. Clinicians and researchers working with older adults may consider these thresholds as an inclusive means to identify candidates for low-risk lifestyle promyogenic and function-promoting therapies. J Am Geriatr Soc 68:1445-1453, 2020.
Keywords: aging; muscle; physical function; sarcopenia.
© 2020 The American Geriatrics Society.
Figures
Comment in
-
Role of Sarcopenia Definition and Diagnosis in Clinical Care: Moving from Risk Assessment to Mechanism-Guided Interventions.J Am Geriatr Soc. 2020 Jul;68(7):1406-1409. doi: 10.1111/jgs.16575. Epub 2020 Jul 7. J Am Geriatr Soc. 2020. PMID: 32633862 No abstract available.
Similar articles
-
Putative Cut-Points in Sarcopenia Components and Incident Adverse Health Outcomes: An SDOC Analysis.J Am Geriatr Soc. 2020 Jul;68(7):1429-1437. doi: 10.1111/jgs.16517. Epub 2020 Jul 7. J Am Geriatr Soc. 2020. PMID: 32633824 Free PMC article.
-
Application of SDOC Cut Points for Low Muscle Strength for Recovery of Walking Speed After Hip Fracture.J Gerontol A Biol Sci Med Sci. 2020 Jun 18;75(7):1379-1385. doi: 10.1093/gerona/glaa076. J Gerontol A Biol Sci Med Sci. 2020. PMID: 32242218 Free PMC article.
-
Identification of Sarcopenia Components That Discriminate Slow Walking Speed: A Pooled Data Analysis.J Am Geriatr Soc. 2020 Jul;68(7):1419-1428. doi: 10.1111/jgs.16524. Epub 2020 Jul 7. J Am Geriatr Soc. 2020. PMID: 32633834 Free PMC article.
-
Global variation in grip strength: a systematic review and meta-analysis of normative data.Age Ageing. 2016 Mar;45(2):209-16. doi: 10.1093/ageing/afv192. Epub 2016 Jan 19. Age Ageing. 2016. PMID: 26790455 Free PMC article. Review.
-
Sarcopenia: Prevalence and associated factors based on different suggested definitions in community-dwelling older adults.Geriatr Gerontol Int. 2016 Mar;16 Suppl 1:110-22. doi: 10.1111/ggi.12723. Geriatr Gerontol Int. 2016. PMID: 27018289 Review.
Cited by
-
Application of Selected Muscle Strength and Body Mass Cut Points for the Diagnosis of Sarcopenia in Men and Women With or at Risk for HIV Infection.J Gerontol A Biol Sci Med Sci. 2020 Jun 18;75(7):1338-1345. doi: 10.1093/gerona/glaa083. J Gerontol A Biol Sci Med Sci. 2020. PMID: 32301484 Free PMC article.
-
Can EWGSOP2 and SDOC Definitions of Sarcopenia Identify Functional Muscle Quality?J Frailty Sarcopenia Falls. 2024 Sep 1;9(3):192-200. doi: 10.22540/JFSF-09-192. eCollection 2024 Sep. J Frailty Sarcopenia Falls. 2024. PMID: 39228672 Free PMC article.
-
Muscle Weakness and Walking Slowness for the Identification of Sarcopenia in the Older Adults from Northern Brazil: A Cross-Sectional Study.Int J Environ Res Public Health. 2022 Jul 29;19(15):9297. doi: 10.3390/ijerph19159297. Int J Environ Res Public Health. 2022. PMID: 35954652 Free PMC article.
-
Hand Grip Strength Relative to Waist Circumference as a Means to Identify Men and Women Possessing Intact Mobility in a Cohort of Older Adults with Type 2 Diabetes.Biomedicines. 2023 Jan 26;11(2):352. doi: 10.3390/biomedicines11020352. Biomedicines. 2023. PMID: 36830889 Free PMC article.
-
Associations of components of sarcopenia with risk of fracture in the Osteoporotic Fractures in Men (MrOS) study.Osteoporos Int. 2022 Aug;33(8):1815-1821. doi: 10.1007/s00198-022-06390-2. Epub 2022 Apr 5. Osteoporos Int. 2022. PMID: 35380213 Free PMC article.
References
-
- Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 2002;50: 889–896. - PubMed
-
- Aging in Place in America: Seniors fear loss of independence, nursing homes more than death. Volume 2017 Clarity and The EAR Foundation: http://www.marketingcharts.com/demographics-and-audiences/boomers-and-ol..., 2007.
Publication types
MeSH terms
Grants and funding
- P30 AG024827/AG/NIA NIH HHS/United States
- 1P30AG031679/NH/NIH HHS/United States
- P30 AG031679/AG/NIA NIH HHS/United States
- AGR0112257/NH/NIH HHS/United States
- P30 DK056341/DK/NIDDK NIH HHS/United States
- and P30AG024827/NH/NIH HHS/United States
- 1U01AG051421/NH/NIH HHS/United States
- U01 AG051421/AG/NIA NIH HHS/United States
- P30AG021332/AG/NIA NIH HHS/United States
- K01 AG057726/AG/NIA NIH HHS/United States
- P30 AG021332/AG/NIA NIH HHS/United States
- AGR0118915/NH/NIH HHS/United States
- P30 AG028747/AG/NIA NIH HHS/United States
- R13 AG060712/AG/NIA NIH HHS/United States
- 1R13AG060712-01/AG/NIA NIH HHS/United States
- P30 AG028740/AG/NIA NIH HHS/United States
- P30AG021332/NH/NIH HHS/United States
- P30AG024827/AG/NIA NIH HHS/United States
- 1U01AG051421/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous